Chemistry & pharmacokinetics
Cagrilintide's once-weekly dosing is not a formulation trick; it is written into the molecule. A fatty-acid tail lets i…
The fatty tail that makes it weekly
Cagrilintide's once-weekly dosing is not a formulation trick; it is written into the molecule. A fatty-acid tail lets it cling to blood albumin and circulate for days, while carefully placed substitutions stop the amylin backbone from clumping.
This unit shows that molecular design and follows the drug through the body: how it is absorbed, why it lasts a week, and why steady titration over months is unavoidable.
Key terms
The molecule, module by module
Cagrilintide is a 32-amino-acid amylin analog with three functional modules: the amylin backbone that binds the receptor, a preserved disulfide loop, and a C20 fatty-diacid tail attached through a linker. Click each module to see its job. Together they solve the two problems of amylin: clumping and short half-life.
The design borrows directly from semaglutide, which uses the same fatty-acid-plus-albumin trick (with a slightly shorter C18 tail). This shared chemistry is why cagrilintide and semaglutide have compatible weekly pharmacokinetics and can share a pen. The modular picture also makes the engineering legible: change the backbone to stop clumping, add the tail to last a week.
AdvancedWhy albumin binding extends half-life
Small peptides are cleared fast by the kidney and chewed up by peptidases. By clinging to albumin, the most abundant blood protein, cagrilintide effectively becomes a large, protected complex that the kidney does not filter and enzymes cannot easily reach. It rides in the bloodstream as a slow-release depot, releasing free peptide gradually. This is the single most important reason a peptide can be dosed once weekly instead of daily.